Is it time to broaden the scope of fertility-sparing treatments for early-stage cervical cancer?

Reflections
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Is it time to broaden the scope of fertility-sparing treatments for early-stage cervical cancer?
Like

Related Content

Fertility and Sterility
Fertility and Sterility Fertility and Sterility

Is it time to broaden the scope of fertility-sparing treatments for early-stage cervical cancer?

Cervical cancer is the fourth leading cause of female cancer and female mortality worldwide. Notably, screening programs, together with socioeconomic changes and advances in diagnostic and treatment algorithms have not only increased awareness but also diminished its incidence and lethality over the…

VOLUME 115, ISSUE 1, P81-82

Authors:

Josep Marí-Alexandre, Ph.D., Juan Gilabert-Estellés, M.D., Ph.D.

Abstract:

Reflections on "Neo-adjuvant chemotherapy followed by conization in cervical cancer <2cm (FIGO STAGE IB2-IIA1): a pilot study" by De Vincenzo et al.

Read the full text here. 

Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Recommended Content